Skip to content
Medical Health Aged Care, Women

Lumi Health: Revolutionising family planning with affordable genetic screening Doctors urged to encourage ‘sliding doors’ test

Lumi Health 3 mins read

Media release: Embargoed until Wednesday November 01, 2025

Lumi Health:  Revolutionising family planning with affordable genetic screening

Doctors urged to encourage ‘sliding doors’ test

Melbourne: Healthcare professionals are being asked to encourage would-be parents to take a simple cheek swab test that screens for their chance of having a child with a severe childhood-onset inherited genetic condition.

Today marks the launch of a ground-breaking genetic screening service, Lumi Health, aimed at empowering Australian couples planning a pregnancy to make informed family planning decisions.

A person kissing a person holding a babyDescription automatically generatedLumi Health is a tri-partnership between myDNA Australia (myDNA), Victorian Clinical Genetic Services (VCGS) and the Murdoch Children's Research Institute (MCRI) - combining over 90 years of genetics experience. Among its ambassadors is Ms Rachael Casella, whose late baby daughter Mackenzie (pictured) inspired the $20 million Medical Research Future Fund (MRFF) project into genetic carrier screening - known as Mackenzie's Mission

Like many couples, Ms Casella and her husband Jonathan had no idea they were both carrying the gene for the devastating condition spinal muscular atrophy (SMA), let alone know that there was a genetic test they could have taken before becoming pregnant.

“One day we had a beautiful, healthy baby and the next day we were told she would die,” Ms Casella says. ”I cannot describe the pain we felt and we will do everything we can to prevent another parent going through that pain.”

From today, the Australian Government will fund, via the Medicare Benefits Scheme (MBS), a genetic carrier screening test for three of the most common inherited conditions - cystic fibrosis, spinal muscular atrophy and fragile X syndrome.

Lumi Health will screen these three conditions for no out-of-pocket cost to parents and will offer expanded carrier screening options for up to another 750 inherited conditions, at a significantly reduced cost. The simple mouth swab can be done at home, anywhere in Australia. 

VCGS Group Leader of Reproductive Genetic Counselling Dr Alison Archibald, describes genetic screening as a ‘sliding doors’ moment for couples planning a family.

With the support of highly trained genetic counsellors, couples are empowered to make choices according to their own values,” Dr Archibald says. ”While the news can be difficult, people value this information and it informs their decision-making around having a family.” 

About one in 50 couples who undergo expanded genetic carrier screening, learn they have an increased chance of having children with a serious inherited condition. 

South Melbourne GP Dr Elaine Sung, says she always encourages any couple planning a pregnancy to take the simple cheek swab test. “This testing is now more accessible than ever and, as doctors, we have a role to play to educate prospective parents how vital it is to be forewarned about their own genetic profile before pregnancy.”

To address the common misunderstanding that only couples who have a family history of a particular inherited condition are likely to be carriers, VCGS regularly hosts CPD education sessions and Lumi Health has created information brochures for GPs.

Founding CEO of MyDNA, Dr Lior Rauchberger, says it is an exciting opportunity to combine expertise and experience from three genetics leaders to deliver this vital service. “Lumi Health can deliver its testing at an affordable price, lowering barriers and expanding access to cutting-edge genetic screening services for Australians,” he says. 

Lumi Health, Mackenzie’s Mission and the Casella family believe that while this is the first time Australian couples can access more affordable carrier screening options, Mackenzie’s legacy will not be fully realised until all Australians can universally access extended genetic carrier screening for all of the 750 severe inherited conditions.  

“This will be Mackenzie’s legacy,’ says Ms Casella. ENDS

Media enquiries: Jannette Cotterell. Executive Counsel Australia +61 419 204 059 jcotterell@executivecounsel.com.au

More images of the Casella family can be found here.

 

Available for interview: 

Dr Alison Archibald

Dr Elaine Sung

Dr Lior Rauchberger

MCRI & VCGS

Doctors of South Melbourne

myDNA

 

About Lumi Health 

The Lumi Health team has been working in genetics for over 35 years. We are medical doctors, genetic counsellors and scientists working together to provide world-leading reproductive genetic screening services to couples across Australia.

Lumi aims to make carrier screening services simple and easily accessible to help support informed reproductive planning. Through this collaborative effort, Lumi Health is set to establish more accessible testing services for Australians, providing families with a wealth of insights to make informed decisions about their future. 

The company is a collaboration between myDNA Australia (myDNA), Victorian Clinical Genetics Services (VCGS), and Murdoch Children's Research Institute (MCRI).

Website: www.lumihealth.com.au

Media

More from this category

  • Environment, Medical Health Aged Care
  • 01/12/2023
  • 10:43
West Australian doctors peak bodies

WA doctors and health professionals call for the government to take urgent action on climate change and end fossil fuel expansion to protect health

On the 1st December, just prior to the COP28 Health Day on the 3rd December, representatives of the medical colleges for general practitioners (GPs), emergency doctors, rural and remote doctors, and surgeons, as well as other doctors and health professionals, gather at 8 am on the steps of Parliament House to call on the WA Government take urgent action on climate change and protect the health of Western Australians. Reiterating calls from medical colleges earlier this year in support of ending fossil fuel expansion and climate action, those gathered today ask the WA government to: End expansion of any new…

  • Medical Health Aged Care
  • 01/12/2023
  • 10:12
Australian Dental Industry Association

ADIA congratulates Senators of the Inquiry into the Provision of and Access to Dental Services in Australia

1 December The Australian Dental Industry Association congratulates the Senators of the Senate Select Committee Inquiry into the Provision of and Access to Dental…

  • Contains:
  • Medical Health Aged Care, Research Development
  • 01/12/2023
  • 09:17
Aegros

Aegros Releases Top-Line Interim Clinical Trial Results of its COVID-19 Hyperimmune

Aegros Releases Top-Line Interim Clinical Trial Results of its COVID-19 Hyperimmune Aegros, an Australian clinical-stage biopharmaceutical company leader in the development and manufacture of plasma derived medicinal products (PDMPs), today announced positive top-line interim results from its CHAT clinical trial. Top-line interim results indicate that Aegros’ COVID-19 hyperimmune provides higher levels of antibodies compared to high-titer convalescent plasma. These results are in line with Aegros’ pre-clinical expectations. CHAT compared Aegros’ COVID-19 hyperimmune to COVID-19 convalescent plasma. The hyperimmune was manufactured using Aegros’ patented Haemafrac® process. A hyperimmune is an intravenous immunoglobulin rich in antibodies that can provide passive immunity for…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time your distribute with Medianet. Pay per release or save with a subscription.